Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Immunogenic polypeptide for enterovirus 71 type VP1 antigen as well as preparation method and application of immunogenic polypeptide

An immunogenic polypeptide and enterovirus technology, applied in the field of immunobiology, to achieve the effects of simple expression and purification methods, good antigenicity and immunogenicity, and simple operation

Active Publication Date: 2016-02-03
SHANDONG UNIV +1
View PDF2 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The BCloop region (91-106 amino acid sites) of VP1 protein is currently recognized as the site of the neutralizing epitope, but whether there are other important epitopes still needs further research and demonstration

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Immunogenic polypeptide for enterovirus 71 type VP1 antigen as well as preparation method and application of immunogenic polypeptide
  • Immunogenic polypeptide for enterovirus 71 type VP1 antigen as well as preparation method and application of immunogenic polypeptide
  • Immunogenic polypeptide for enterovirus 71 type VP1 antigen as well as preparation method and application of immunogenic polypeptide

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] Example 1: Expression and purification of the immunogenic polypeptide of the VP1 antigen of enterovirus 71

[0054] 1. Amplify the cDNA of EV71SDLY107 strain virus

[0055] Use OMEGA's ViralRNAkit kit to extract the RNA of SDLY107 strain virus. The virus strain SDLY107 was isolated from a child with hand, foot and mouth disease who died in Linyi People's Hospital of Shandong Province. Strong, with obvious animal pathological features), the strain has been analyzed for its full sequence (GenBank: JX244186.1), and cDNA was generated by reverse transcription using TOYOBO's ReverTraAceqPCRKit.

[0056] 2. Primer design and PCR amplification

[0057] The full-length cDNA of SDLY107 was used as a PCR template to design primers for PCR amplification. The primer sequences are shown in Table 1:

[0058] Table 1 Primer Sequence

[0059]

[0060] Using SDLY107 full-length cDNA as PCR template, SpeIVP1PrimerF as upstream primer, and HindIIIVP1PrimerR as downstream primers to ...

Embodiment 2

[0068] Example 2: Antigenic Identification of VP1 Protein and Immunogenic Polypeptides

[0069] 1. Identification of antigenicity by Western Blot method:

[0070] Add the protein sample prepared in Example 1 to 5×SDS-PAGE loading buffer at a ratio of 1:4, mix evenly, boil in water for 7 minutes, centrifuge at 10,000 r / min at 4°C for 2 minutes, take the supernatant for electrophoresis, and transfer the bacterial liquid protein On the nitrocellulose membrane, 5% skimmed milk powder was blocked for 40min; the primary antibody was incubated with mouse-derived anti-EV71 polyclonal antibody (1:5000) at 4°C overnight, and the membrane was washed 3 times with TBST, and the secondary antibody was added with horseradish peroxidase Labeled goat anti-mouse IgG antibody (1:5000), incubated at room temperature for 30 minutes, washed the membrane three times with TBST, and added DAB for color development. At the same time, the pET-49b (+) empty vector was transformed into DE3 Escherichia co...

Embodiment 3

[0077] Example 3: Identification of Immunogenicity of VP1 Protein and Immunogenic Polypeptide

[0078] The VP1 protein and immunogenic polypeptide purified in Example 1 were mixed with Freund's adjuvant at a ratio of 1:1 by volume, and then Balb / c mice were immunized, and 5 mice were immunized for each protein, and immunized 4 times in total. Initial immunization with 1.0 mg protein plus Freund's incomplete adjuvant, 2 weeks later immunization with 0.5 mg protein plus Freund's incomplete adjuvant, followed by continuous immunization with 0.5 mg protein plus Freund's incomplete adjuvant twice at intervals of 1 week, and one week after the last immunization Afterwards, the eyeballs were removed and blood was taken; at the same time, blood was taken from mice immunized with pET-49b(+) empty vector expressing protein as a negative control. WesternBlot was used to detect whether the serum could specifically react with the EV71 virus to detect protein immunogenicity. The result is ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of immunobiology, relates to immunogenic polypeptide for an enterovirus 71 type VP1 antigen as well as a preparation method and application of immunogenic polypeptide, in particular to immunogenic polypeptide for the enterovirus 71 type VP1 antigen, which has an amino acid sequence shown in any of sequence tables SEQ ID No.1-SEQ ID No.5 or has an amino acid sequence which has the same function and formed by replacing, deleting or adding one or more amino acids. The invention further relates to the preparation method of immunogenic polypeptide and application of immunogenic polypeptide to preparation of diagnostic reagents for EV71 viruses. The immunogenic polypeptide has good antigenicity and immunogenicity and provides a research foundation for development of diagnostic reagents and research on vaccines of EV71 at an early stage.

Description

technical field [0001] The invention belongs to the technical field of immunobiology, and in particular relates to an immunogenic polypeptide of enterovirus 71 type VP1 antigen, a preparation method and application thereof. Background technique [0002] EV71 is a single-stranded positive-sense RNA virus belonging to the genus Enterovirus A of the Picornaviridae family. Its infection can cause hand, foot and mouth disease in infants and young children. The main manifestations of the disease are fever, diarrhea and herpetic angina. Different from typical HFMD, infection with certain EV71 strains can cause severe HFMD, with complications including aseptic meningitis, encephalitis, polio-like paralysis, neurogenic pulmonary edema and even death. The incidence of EV71 infection is widespread, and its epidemic range spreads to Asia, Europe, North America, Australia, etc., and the mortality rate is high. It is a public health problem that is currently receiving considerable attenti...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/085C12N15/41C12N15/70C12N1/21G01N33/68G01N33/569
CPCC07K14/005C12N2770/32322G01N33/56983G01N33/68G01N2333/085
Inventor 温红玲郝树彬马英伟陶泽新王志玉庄志超白永娟王莉鸿李纯
Owner SHANDONG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com